Compensation: $75–$87 per hour, commensurate with experience
About the Opportunity
We are seeking an experienced Nurse Practitioner (NP) or Physician Assistant (PA) to join a clinical research site in Philadelphia, PA, on a part-time basis.
This position will focus primarily on administering BOTOX® injections for a chronic migraine clinical trial, while also providing additional clinical support for pharmaceutical-sponsored research studies.
The ideal candidate will have hands‑on BOTOX® or neurotoxin injection experience, strong clinical assessment skills, and the ability to work collaboratively with Principal Investigators and clinical research teams.
Prior clinical research experience is preferred but not required.
Key Responsibilities
- Administer BOTOX® injections to clinical trial participants in accordance with study protocols, with a primary focus on chronic migraine treatment.
- Perform subcutaneous and intramuscular injections as required by study protocols.
- Place IV catheters and initiate and monitor IV infusions.
- Assist with investigational product preparation and administration in accordance with study requirements.
- Conduct physical examinations and other protocol‑required clinical assessments within the appropriate scope of practice.
- Review laboratory results, ECGs, vital signs, and other clinical data in collaboration with Principal Investigators.
- Monitor participants for adverse reactions, changes in clinical condition, and potential safety concerns.
- Assist with difficult blood draws, phlebotomy, and IV placement when needed.
- Review medical records, reconcile medications, and verify participant medical histories.
- Support the identification, documentation, and reporting of adverse events (AEs) and serious adverse events (SAEs).
- Provide clinical support during medical emergencies when necessary.
- Maintain accurate, timely, and compliant clinical documentation in accordance with study protocols, FDA regulations, and Good Clinical Practice (GCP) guidelines.
- Collaborate with Principal Investigators and clinical research staff to ensure participant safety and successful study execution.
Qualifications & Requirements
Required Qualifications:
- Licensed Nurse Practitioner (NP) or Physician Assistant (PA) in Pennsylvania.
- Current, unrestricted Pennsylvania RN license and CRNP certification with applicable national NP certification, OR current, unrestricted Pennsylvania PA license and registration with NCCPA certification (PA-C).
- Bachelor's degree and appropriate advanced clinical degree for NP or PA practice.
- At least 1 year of experience administering BOTOX® or other neurotoxin injections, with a minimum of 2 patients treated or 8 treatment sessions completed.
- Candidates with relevant injection experience in dermatology or aesthetics may also be considered, subject to sponsor approval.
- Strong clinical assessment skills and attention to detail.
- Ability to follow clinical trial protocols and maintain accurate documentation.
- Availability to work on‑site in Philadelphia a minimum of 2 weekdays per week.
Preferred Qualifications:
- 2+ years of professional experience as a Nurse Practitioner or Physician Assistant.
- Previous experience administering BOTOX® for chronic migraine treatment.
- Prior experience working in clinical research or pharmaceutical‑sponsored clinical trials.
- BLS/CPR certification.
- Familiarity with FDA regulations and Good Clinical Practice (GCP) guidelines.
Schedule & Compensation
- Location: Philadelphia, PA (on‑site)
- Schedule: Minimum 2 weekdays per week, with scheduling based on clinical trial activities and participant visits.
- Hourly Rate: $75–$87, depending on qualifications and experience.
- 401(k) employer matching
Why Consider This Opportunity?
This is an excellent opportunity for an experienced NP or PA looking for a flexible, part‑time position while contributing to innovative clinical research.
The role offers the opportunity to apply specialized injection skills in a research setting, collaborate with experienced clinical professionals, and contribute to the development of potential treatments for individuals living with chronic migraine.